The potential of ruxolitinib as a senomorphic therapy in alleviating neovascular age-related macular degeneration : Ruxolitinib inhibits CNV. [PDF]
Wang Y +17 more
europepmc +1 more source
The APOE ε2 allele is associated with risk of neovascular age-related macular degeneration in a Russian cohort. [PDF]
O Kozhevnikova S +5 more
europepmc +1 more source
Early retinal volume changes after switching to brolucizumab in refractory neovascular age-related macular degeneration. [PDF]
Matsuki T +4 more
europepmc +1 more source
AI-Based OCT Assessment of Anatomic Response During the Loading Phase of Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration. [PDF]
Nassisi M +14 more
europepmc +1 more source
Durability of Three Monthly Loading Doses with Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration. [PDF]
Turan L +5 more
europepmc +1 more source
Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration. [PDF]
Ruiz-Medrano J +3 more
europepmc +1 more source
Two-dose aflibercept 8 mg versus three-dose aflibercept 2 mg loading for treatment-naïve neovascular age-related macular degeneration. [PDF]
Shirakami M +12 more
europepmc +1 more source
Acute onset of neovascular age-related macular degeneration after initiation of tirzepatide. [PDF]
Takebayashi K +6 more
europepmc +1 more source
Noninfectious intraocular inflammation with hypopyon after intravitreal aflibercept 8 mg injection for neovascular age-related macular degeneration: a case report. [PDF]
Kamao H +4 more
europepmc +1 more source
Time to Exudative Recurrence After Complete Fluid Resolution Following Anti-VEGF Loading in Neovascular Age-Related Macular Degeneration. [PDF]
Kook K, Park D, Lee G, Ji YS.
europepmc +1 more source

